<DOC>
	<DOCNO>NCT02846181</DOCNO>
	<brief_summary>The primary objective study : - To assess mass balance recovery single PO dose [ 14C ] -SK-1405 - To provide plasma , urine faecal sample metabolite profile structural identification</brief_summary>
	<brief_title>A Study Assess Mass Balance Recovery , Metabolite Profile Metabolite Identification 14C-SK-1405</brief_title>
	<detailed_description />
	<mesh_term>Pruritus</mesh_term>
	<criteria>Healthy male Age 30 65 year age Body mass index 18.0 30.0 kg/m2 Must willing able communicate participate whole study Must provide write informed consent Must regular bowel movement ( i.e . average stool production ≥1 ≤3 stool per day ) Must agree use adequate method contraception Participation clinical research study within 3 month prior IMP dose Subjects study site employee , immediate family member study site sponsor employee Subjects previously enrol study Subjects dose SK1405 past Subjects taking , take , antiepileptic and/or antidepressant medication 6 month prior dose Subjects take , take , prescribed medication 28 day prior dose , unless judge clinically significant investigator sponsor Subjects taking , take , overthecounter medication ( exception 2,000 mg/day paracetamol/acetaminophen ) 7 day prior dose , unless judge clinically significant investigator sponsor Use , 28 day prior dose , medicine herbal remedy ( St John 's wort ) know induce inhibit CYP enzymes , unless judge clinically significant investigator sponsor History drug alcohol abuse past 2 year History clinically significant neurological condition A QTcF &gt; 450 msec screening , admission predose ( confirm repeat ECG ) Regular alcohol consumption male &gt; 21 unit per week ( 1 unit = ½ pint beer , 25 mL 40 % spirit 125 mL glass wine ) Current smoker smoke within last 12 month ; include cigarette , ecigarettes nicotine replacement product . A breath carbon monoxide read great 10 ppm screen admission Radiation exposure , include present study , exclude background radiation include diagnostic xrays medical exposure , exceed 5 mSv last 12 month 10 mSv last 5 year . No occupationally expose worker , define Ionising Radiation Regulations 1999 , shall participate study Subjects enrol ADME study last 12 month Subjects suitable vein multiple venepunctures/cannulation assess investigator screen Clinically significant abnormal biochemistry , haematology urinalysis judge investigator , include AST , ALT alkaline phosphatase &gt; 1.5 × upper limit normal confirm repeat test 18 . Positive drug abuse test result Positive hepatitis B surface antigen ( HBsAg ) , hepatitis C virus antibody ( HCV Ab ) human immunodeficiency virus ( HIV ) result Evidence renal impairment screening , indicate estimate creatinine clearance ( CLcr ) &lt; 90 mL/min use CockcroftGault equation History clinically significant psychiatric , cardiovascular , renal , hepatic , chronic respiratory gastrointestinal disease judge investigator History gastrointestinal surgery ( except appendectomy ) condition may affect absorption , distribution , metabolism excretion study drug opinion investigator Serious adverse reaction serious hypersensitivity drug formulation excipients Presence history clinically significant allergy ( include food drug allergy ) require treatment , judge investigator . Hayfever allow unless active Donation loss great 400 mL blood within 3 month prior IMP dose Subjects consume St John 's wort , red wine , Seville oranges , grapefruit grapefruit juice within 7 day prior dose . Subjects must willing refrain consuming product last PK sample Failure satisfy investigator fitness participate reason</criteria>
	<gender>Male</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>